On behalf of BioCryst UK Ltd., we are pleased to invite you to join them for an educational webinar, on Thursday 9 October 2025, 13:00 – 13:45.
This session will explore the clinical considerations surrounding oral kallikrein inhibitors. Attendees will examine how the shift from injectable kallikrein will impact clinical experiences. The discussion will also provide an opportunity to engage with expert clinicians.
Programme:
| Time (BST) | Session | Speaker |
| 13:00-13:05 | Welcome and introduction | Dr Patrick Yong, Consultant Immunologist, Frimley Health Foundation |
| 13:05-13:15 | The shift from injectable to oral kallikrein inhibitors - clinical considerations and recommendations | Dr Anthony Dorr, Consultant Immunologist, Barts Health Trust |
| 13:15-13:25 | Case study of clinical experience and recommendations | Dr Anthony Dorr, Consultant Immunologist, Barts Health Trust |
| 13:25-13:35 | Exploring the clinical evidence of Berotralstat | Dr Anthony Dorr, Consultant Immunologist, Barts Health Trust |
| 13:35-13:45 | Q&A and closing remarks | All speakers |
Registration:
This webinar is free to attend. Register here.